Entera Bio Ltd (ENTX) Stock Price, Quote, News & History

ENTXNASDAQ
$1.71
0.053.01%
At close: Jul 6, 5:00 PM EST
$1.62
-0.0856-5.01%
After Hours: 9:23 AM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-9.06M
Investing Cash Flow (TTM)
-99.00K
Financing Cash Flow (TTM)
503.00K
Free Cash Flow (TTM)
-9.15M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-8.62M

Analyst Trends and Forecast

1
Feb
1
Apr
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$78.13M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
7.66
Earnings Yield % (TTM)
-15.66%
Earnings Yield % (FWD)
-20.48%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.22

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$4.14M
Debt to Equity
0.04
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$1.69
Close
$1.71
Volume / Avg.
573.26K / 1.02M
Day Range
$1.63 - $1.86
52 Wk Range
0.91 - 3.22
Market Cap
$79.96M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
67
Short Interest
0.38%
Days to Cover
2.88

About

Sector
Health Care
Industry
Biotechnology
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Entera Bio (ENTX) stock?

A

You can purchase shares of Entera Bio (NASDAQ:ENTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Entera Bio (ENTX) competitors?

A

There are no as such competitors for Entera Bio.

Q

What is the forecast, or price target, for Entera Bio (ENTX) stock?

A

Entera Bio has a consensus price target of $9.00.

Q

What is the current price for Entera Bio (ENTX)?

A

The stock price for Entera Bio (NASDAQ: ENTX) is $1.6244 last updated July 6, 2026 at 9:23 AM EDT.

Q

Does Entera Bio (ENTX) pay a dividend?

A

There are no upcoming dividends for Entera Bio.

Q

When is Entera Bio (NASDAQ:ENTX) reporting earnings?

A

Entera Bio does not have any upcoming earnings scheduled.

Q

Is Entera Bio (ENTX) going to split?

A

There is no upcoming split for Entera Bio.

Q

What sector and industry does Entera Bio (ENTX) operate in?

A

Entera Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.